SV

Street Verdict

Analyst Scorecard

A record of what Chakri Lokapriya said publicly, with the source. Not advice.

Pending — not yet graded
“Bullish on the Pharma sector, particularly the CDMO pack, which is showing revival with pricing power and volume picking up outside India. This makes it a sector where buying is recommended, alongside IT.”
Nifty PharmaBullishCalled 25 Oct 2024
Verdict:PENDING

This call has no verdict yet — it is graded HIT or MISS against real price data once a close decides it. Save it above to find it again from your profile.

Read the original articleSee Chakri Lokapriya’s full track record